Reference number : 276-2008-2009-Q4-00236, amendment number : , agreement type : C, recipient legal name : Origin BioMed Inc.|Origin BioMed Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3J 1N7, program name english : Business Development Program, program name french : Programme de développement des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 194612, agreement title french : 194612, agreement number : 194612, agreement value : 498375.0, agreement start date : 2009-02-12, agreement end date : 2010-02-28, description english : Marketing to export analgesic drug (new SKU) into US market, description french : Market. pr export. d'analgés. (nouv. UGS) sur marché amér., expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement conditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique